Nigeria: Funding Hinders Production of Niprisan, Local Sickle Cell Drug

12 February 2012

Inadequate funding is likely to hinder plans by Nigerian Institute for Pharmaceutical Research and Development to get a major drug, Niprisan, listed by Nigeria's food and drug agency this year.

The institute says it is short of funding, despite a recent N35 million increase in budgetary allocation this year. It is an increase from a previous N52 million yearly budget to N87 million this year.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.